Exosome-based immunotherapy

117Citations
Citations of this article
123Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Exosomes are small membrane vesicles originating from late endosomes and secreted by hematopoietic and epithelial cells in culture. Exosome proteic and lipid composition is unique and might shed some light into exosome biogenesis and function. Exosomes secreted from professional antigen-presenting cells (i.e., B lymphocytes and dendritic cells) are enriched in MHC class I and II complexes, costimulatory molecules, and hsp70-90 chaperones, and have therefore been more extensively studied for their immunomodulatory capacities in vitro and in vivo. This review will present the main biological features pertaining to tumor or DC-derived exosomes, will emphasize their immunostimulatory function, and will discuss their implementation in cancer immunotherapy.

Cite

CITATION STYLE

APA

Chaput, N., Taïeb, J., Schartz, N. E. C., André, F., Angevin, E., & Zitvogel, L. (2004, March). Exosome-based immunotherapy. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-003-0472-x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free